-+ 0.00%
-+ 0.00%
-+ 0.00%

BeOne Medicines Reports 74% Six-Year Progression-Free Survival with BRUKINSA in Treatment-Naïve CLL

Reuters·12/08/2025 13:01:32

Please log in to view news